Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000001119
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies Against Cell-To-Cell Transmission of HIV-1 With Transmitted Founder Envs

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2017English

Development of Tetravalent, Bispecific CCR5 Antibodies With Antiviral Activity Against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Chemically Modified Bispecific Antibodies

Science-Business eXchange
2012English

Broad and Potent Neutralization of HIV-1 by Human-Llama Fusion Antibodies Derived From Immunized Llamas

Retrovirology
VirologyInfectious Diseases
2012English

A Pathway to HIV-1 Neutralization Breadth

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Tandem Bispecific Neutralizing Antibody Eliminates HIV-1 Infection in Humanized Mice

Journal of Clinical Investigation
Medicine
2018English

Maturation-Induced Cloaking of Neutralization Epitopes on HIV-1 Particles

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2011English

Monoclonal and Bispecific Antibodies as Novel Therapeutics

Archivum Immunologiae et Therapiae Experimentalis
MedicineAllergyImmunology
2006English

Recent Advances of Bispecific Antibodies in Solid Tumors

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy